Parkinson’s Disease

Pioneers of Parkinson’s disease research are gathering at Vanderbilt University Medical Center today to celebrate the end of a study that was an important first step in the quest to find a way to slow the progression of the degenerative movement disorder. Read More

Vanderbilt University researchers were one of nine teams invited to participate in the National Institute of Biomedical Imaging and Bioengineering’s 10th anniversary technology showcase June 22 in Bethesda, Maryland. NIBIB is an institute within the National Institutes of Health. Read More

Reid Thompson talks with Lola Chambless in the neurosurgery OR. (Anne Rayner/VUMC) The May program for My Health Chat will be the fascinating field of neuroscience. Panelists will be Reid Thompson, chair of neurosurgery and director of the Vanderbilt Brain Tumor Center, and Jeff Conn,… Read More

Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience. Read More

When the Nashville Predators take the ice—it’s all about strength, precision and teamwork. But when a beloved former coach with the Preds started feeling the harsh symptoms of Parkinson’s Disease—he turned to a team here at Vanderbilt. Coach Brent Peterson allowed VUCast’s Carole Bartoo and Mike Todd inside the operating… Read More

This Week on VUCast, Vanderbilt’s weekly newscast  highlighting  research, experts, students, sports and everything Vanderbilt: ·         Inside A Preds coach’s deep brain stimulation surgery ·         How nicotine could impact memory ·         Why a research lab wants Vandy undergrads [vucastblurb]… Read More

The progression of new drug candidates for schizophrenia with partner Janssen Pharmaceutica is the latest evidence that a new collaborative model for drug discovery pioneered at Vanderbilt may help identify and develop innovative candidate drugs for treatment of major brain disorders. Read More

Neuronal activity in a deep brain region increases as Parkinson’s disease advances, a new study suggests. Read More

Researchers at Vanderbilt University Medical Center have made substantial progress in developing potential new treatments for Parkinson’s disease, schizophrenia and fragile X syndrome, the most common genetic form of autism. Read More

Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects. Read More

Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson's disease, schizophrenia and other disorders of the brain. Read More